ACLX vs MDT · rev $107.9M vs P/E 21, rev $36.36B
Arcellx Inc (ACLX) versus Medtronic PLC (MDT) — a side-by-side from cached financials, not a winner call.
Arcellx Inc (ACLX) is a biotechnology company listed on NASDAQ.
Medtronic PLC (MDT) is a medical devices company listed on US.
Latest reported ACLX revenue for 2024-12-31 was $107.9M. Net income was -$107.3M. Revenue was down 2.2% from 2023-12-31 to 2024-12-31. ACLX currently screens at market cap $6.73B.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
ACLX currently screens at market cap $6.73B. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Not investment advice. Open the ACLX and MDT stock pages for the full models.
Not investment advice.